American Association for Cancer Research

Skip to Main Content

Table 4

E75 induced IFN-γ secretion in pre- and postvaccination patient PBMCs

Patient no.	Vaccination status	Stimulation group/IFN-γ (pg/ml)
				NP^a	E75	NP	E75
				−IL-12			+IL-12
6	Post 1	0.0	0.0	0.0	0.0
7	Post 1	0.0	0.0	0.0	65.0
9	Post 1	0.0	0.0	0.0	106.3
10	Pre	0.0	0.0	0.0	405.5
	Post 1	0.0	108.0	479.7	782.2
	Post 2^b	176	211	194	276
11	Pre	0.0	0.0	45.4	747.0
	Post 1	0.0	0.0	56.5	840.1
	Post 2	0.0	0.0	12.7	733.9
14	Post 2	146	212	316	455

Patient no.	Vaccination status	Stimulation group/IFN-γ (pg/ml)
				NP^a	E75	NP	E75
				−IL-12			+IL-12
6	Post 1	0.0	0.0	0.0	0.0
7	Post 1	0.0	0.0	0.0	65.0
9	Post 1	0.0	0.0	0.0	106.3
10	Pre	0.0	0.0	0.0	405.5
	Post 1	0.0	108.0	479.7	782.2
	Post 2^b	176	211	194	276
11	Pre	0.0	0.0	45.4	747.0
	Post 1	0.0	0.0	56.5	840.1
	Post 2	0.0	0.0	12.7	733.9
14	Post 2	146	212	316	455

^a

No peptide control.

^b

Supernatant collected after two rounds of stimulation; all determinations represent the highest values of IFN-γ in 24-h supernatants.